StockNews.com assumed coverage on shares of Oragenics ( NYSEAMERICAN:OGEN – Free Report ) in a research note published on Wednesday. The firm issued a sell rating on the biotechnology company's stock. Oragenics Stock Performance Shares of Oragenics stock opened at $3.27 on Wednesday. The firm has a market capitalization of $6.41 million, a price-to-earnings ratio of -25.15 and a beta of 0.19. Oragenics has a fifty-two week low of $2.60 and a fifty-two week high of $24.00. The stock has a 50 day moving average of $3.

https://www.dailypolitical.com/2023/07/08/oragenics-nyseamericanogen-coverage-initiated-by-analysts-at-stocknews-com.html

#dailypolitical